Istanbul Physical Medicine Rehabilitation Training and Research Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2019
NCT04283591
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Istanbul Physical Medicine Rehabilitation Training and Research Hospital | Istanbul Physical Medicine Rehabilitation Training & Research Hospital | Istanbul Physical Medicine Rehabilitation Traning and Research Hospital | İstanbul Physical Therapy Rehabilitation Training & Research Hosptial

Active Ingredients

Drugs in Other Trials (5)

dextrose (2 trials)

lidocaine (xylocaine) (1 trial)

pregabalin (lyrica) (1 trial)

rutin (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 5
  • # of Trial APIs: 5